STAVE - SAXAGLIPTIN TRIAL TO ASSESS VASCULAR ENDPOINTS IN DIABETES MELLITUS
associated with 4424 other trademarks
Medical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations for human use

Words that describe this trademark:

conducting clinical trials  medical scientific research  scientific research  clinical trials  research conducting  pharmaceutical preparations  preparations  relating  human  trials 

Serial Number:

77813061

Mark:

STAVE - SAXAGLIPTIN TRIAL TO ASSESS VASCULAR ENDPOINTS IN DIABETES MELLITUS

Status:

Abandoned-Express

Status Date:

04-12-2010

Filing Date:

Registration Number:

N/A

Registration Date:

N/A

Goods and Services:

Medical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations for human use

Mark Description:

N/A

Class:

Scientific and technological services

Type of Mark:

Servicemark

Published for Opposition Date:

N/A

Mark Drawing Status:

Standart Character Mark

Abandon Date:

04-09-2010

Business Name:

BRISTOL-MYERS SQUIBB COMPANY

Correspondent Name:

Recent Trademark filings by this company